Bio-Techne (TECH) Total Liabilities (2009 - 2026)
Bio-Techne's quarterly Total Liabilities came in at $465.3 million in Q1 2026, down 25.7% year-on-year from $626.2 million in Q1 2025, and down 9.07% quarter-over-quarter from $511.7 million in Q4 2025.
Bio-Techne has reported Total Liabilities for 18 years, with the latest figure at $465.3 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 25.7% year-over-year to $465.3 million; the trailing twelve-month figure through Mar 2026 stood at $465.3 million (down 25.7% YoY), and the FY2025 full-year result was $639.1 million, up 0.64% from the prior year.
- Total Liabilities for Q1 2026 stood at $465.3 million, down from $511.7 million in the prior quarter.
- The five-year high for Total Liabilities was $767.2 million in Q4 2023, with the low at $465.3 million in Q1 2026.
- Average Total Liabilities over 5 years is $621.0 million, with a median of $599.6 million recorded in 2022.
- Year-over-year, Total Liabilities surged 43.05% in 2023 and dropped 25.7% in 2026.
- Tracing TECH's Total Liabilities over 5 years: stood at $536.3 million in 2022, then surged by 43.05% to $767.2 million in 2023, then fell by 22.84% to $591.9 million in 2024, then dropped by 13.55% to $511.7 million in 2025, then fell by 9.07% to $465.3 million in 2026.
- The last three Total Liabilities figures came in at $465.3 million (Q1 2026), $511.7 million (Q4 2025), and $560.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 465.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 465.30 Mn |
| Dec 31, 2025 | 511.71 Mn |
| Sep 30, 2025 | 560.33 Mn |
| Jun 30, 2025 | 639.06 Mn |
| Mar 31, 2025 | 626.23 Mn |
| Dec 31, 2024 | 591.93 Mn |
| Sep 30, 2024 | 597.37 Mn |
| Jun 30, 2024 | 635.02 Mn |
| Mar 31, 2024 | 706.80 Mn |
| Dec 31, 2023 | 767.19 Mn |
| Sep 30, 2023 | 757.61 Mn |
| Jun 30, 2023 | 672.18 Mn |
| Mar 31, 2023 | 710.01 Mn |
| Dec 31, 2022 | 536.30 Mn |
| Sep 30, 2022 | 599.57 Mn |
| Jun 30, 2022 | 593.79 Mn |
| Mar 31, 2022 | 586.57 Mn |
| Dec 31, 2021 | 602.32 Mn |
| Sep 30, 2021 | 623.23 Mn |
| Jun 30, 2021 | 691.72 Mn |
| Mar 31, 2021 | 536.70 Mn |
| Dec 31, 2020 | 537.01 Mn |
| Sep 30, 2020 | 613.81 Mn |
| Jun 30, 2020 | 646.40 Mn |
| Mar 31, 2020 | 707.75 Mn |
| Dec 31, 2019 | 675.07 Mn |
| Sep 30, 2019 | 750.80 Mn |
| Jun 30, 2019 | 718.82 Mn |
| Mar 31, 2019 | 726.35 Mn |
| Dec 31, 2018 | 748.41 Mn |
| Sep 30, 2018 | 762.73 Mn |
| Jun 30, 2018 | 514.14 Mn |
| Mar 31, 2018 | 559.52 Mn |
| Dec 31, 2017 | 557.60 Mn |
| Sep 30, 2017 | 567.30 Mn |
| Jun 30, 2017 | 608.59 Mn |
| Mar 31, 2017 | 625.51 Mn |
| Dec 31, 2016 | 629.45 Mn |
| Sep 30, 2016 | 622.11 Mn |
| Jun 30, 2016 | 250.30 Mn |
| Mar 31, 2016 | 268.96 Mn |
| Dec 31, 2015 | 277.11 Mn |
| Sep 30, 2015 | 290.37 Mn |
| Jun 30, 2015 | 216.43 Mn |
| Mar 31, 2015 | 284.24 Mn |
| Dec 31, 2014 | 298.32 Mn |
| Sep 30, 2014 | 224.85 Mn |
| Jun 30, 2014 | 67.23 Mn |
| Mar 31, 2014 | 53.53 Mn |
| Dec 31, 2013 | 53.64 Mn |
| Sep 30, 2013 | 52.53 Mn |
| Jun 30, 2013 | 40.56 Mn |
| Mar 31, 2013 | 40.78 Mn |
| Dec 31, 2012 | 30.01 Mn |
| Sep 30, 2012 | 32.02 Mn |
| Jun 30, 2012 | 44.88 Mn |
| Mar 31, 2012 | 39.54 Mn |
| Dec 31, 2011 | 26.74 Mn |
| Sep 30, 2011 | 39.08 Mn |
| Jun 30, 2011 | 31.55 Mn |
| Mar 31, 2011 | 16.54 Mn |
| Dec 31, 2010 | 13.67 Mn |
| Sep 30, 2010 | 16.06 Mn |
| Jun 30, 2010 | 17.02 Mn |
| Jun 30, 2009 | 15.52 Mn |